Page last updated: 2024-12-07
1,1,2-triphenylbut-1-ene
1,1,2-Triphenylbut-1-ene is a **synthetic organic compound** with the molecular formula C22H20. Here's a breakdown of its structure and potential importance in research:
**Structure:**
* **Triphenyl:** This part of the name indicates three phenyl groups (C6H5) attached to the molecule.
* **But-1-ene:** This indicates a four-carbon chain (but-) with a double bond at the first carbon (1-ene).
The structure can be represented as:
```
Ph
|
Ph - C - CH - CH3
|
Ph
```
Where Ph represents a phenyl group.
**Importance in Research:**
1,1,2-Triphenylbut-1-ene is not a widely studied compound, and its specific importance in research is difficult to determine without further context. However, it's worth noting that:
* **Potential for Studying Reactivity:** Due to the presence of multiple phenyl groups and the double bond, this compound could be a good model for studying various chemical reactions, especially those involving electrophilic attack or the formation of carbocations.
* **Possible Precursor:** It could serve as a starting material for synthesizing other organic compounds with complex structures.
* **Stereochemistry:** The presence of chiral centers in this molecule allows for the exploration of stereoisomerism (different spatial arrangements of atoms) and their impact on chemical properties and reactions.
**To understand its specific relevance, you'd need more information about the research context, such as:**
* **What specific properties or reactions are being studied?**
* **What are the goals of the research?**
* **Is it being used as a reagent, catalyst, or product?**
If you can provide more context, I can give you a more accurate and specific explanation of its importance in research.
Cross-References
ID Source | ID |
PubMed CID | 124958 |
CHEMBL ID | 418153 |
MeSH ID | M0109475 |
Synonyms (7)
Synonym |
1,1,2-tpe |
CHEMBL418153 |
63019-13-6 |
benzene, 1,1',1''-(1-ethyl-1-ethenyl-2-ylidene)tris- |
1,1,2-triphenylbut-1-ene |
triphenylbutene |
DTXSID70212259 |
Bioassays (2)
Assay ID | Title | Year | Journal | Article |
AID123560 | Anti-neoplastic effect in estrogen and progesterone receptor positive hormone-dependent postmenopausal human mammary carcinoma bearing mice at 2.2 mg/kg/day | 1982 | Journal of medicinal chemistry, Sep, Volume: 25, Issue:9
| 1,1,2-triphenylbut-1-enes: relationship between structure, estradiol receptor affinity, and mammary tumor inhibiting properties. |
AID71147 | Binding affinity against Estrogen receptor in calf-uterine cytosol relative to 17-beta-estradiol using [3H]estradiol. | 1982 | Journal of medicinal chemistry, Sep, Volume: 25, Issue:9
| 1,1,2-triphenylbut-1-enes: relationship between structure, estradiol receptor affinity, and mammary tumor inhibiting properties. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 5 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.66
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.66 (24.57) | Research Supply Index | 1.79 (2.92) | Research Growth Index | 4.45 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |